ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014)
ProQR Therapeutics (PRQR) posted Change in Account Payables of $464552.0 for Q3 2014, up 293.93% sequentially from $117928.4 in Q3 2013, and up 293.93% YoY from $117928.4 in Q3 2013.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014) Analysis & Trends
ProQR Therapeutics has reported Change in Account Payables for 2 years, with the latest figure at $464552.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - | - |